來源:[1] Cogent Biosciences因積極臨床試驗數據股價飆升 (https://seekingalpha.com/article/4841864-coge ...)[2] Cogent Biosciences股價因III期胃腸道癌數據飆升 - Clinical Trials Arena (https://vertexaisearch.cloud.google.com/groun ...)[3] Cogent Biosciences股價因Bezuclastinib積極3期試驗結果飆升120% (https://vertexaisearch.cloud.google.com/groun ...)